Novel gene-editing therapy continues to show positive results in sickle cell patients

18 patients show no evidence of disease in ongoing clinical trial

2024-06-14

(Press-News.org) Researchers have presented the latest findings from a clinical trial aimed at discovering a cure for sickle cell disease, a painful genetic blood disorder with limited treatment options.

Conducted as part of the multicenter RUBY Trial, researchers shared data on the safety and effectiveness of renizgamglogene autogedtemcel (reni-cel, formerly known as EDIT-301), an experimental one-time gene editing cell therapy, among its 18 patients at the European Hematology Association 2024 Hybrid Congress (EHA) in Madrid, Spain.

This innovative treatment modifies a patient’s own blood-forming stem cells to correct the mutation responsible for sickle cell disease.

The 18 patients – two of whom were treated at Cleveland Clinic Children’s – underwent a procedure where their stem cells were first collected for gene editing.

They then received chemotherapy to clear remaining bone marrow, making room for the repaired cells which were later infused back into their body.

The treatment was well-tolerated with no serious side effects reported. Following treatment, all patients successfully regained their white blood cells and platelets. Importantly, all patients have remained free of painful events since treatment, and those followed for five months or greater have seen their anemia resolve.

“It’s encouraging that this gene-editing treatment continues to show promising efficacy for sickle cell patients,” said Rabi Hanna, M.D., chairman of the division of pediatric hematology oncology and blood and marrow transplantation at Cleveland Clinic Children’s and the RUBY trial’s presenting investigator. “These latest results offer hope that this new experimental treatment will continue to show progress and get us closer to a functional cure for this devastating disease.”

A significant milestone of the trial is the first use of CRISPR/Cas12a gene-editing technology in a human study to alter the defective gene responsible for sickle cell disease. This precision tool is used to modify blood stem cell genomes to enable robust and healthy blood cell production.
In the United States, between 1 million to 3 million people carry the sickle cell trait, while approximately 100,000 individuals have sickle cell disease. This trait and disease are more common among certain ethnic groups, including African Americans, where approximately 1 in every 365 babies are born with sickle cell disease.

Sickle cell disease is a genetic blood disorder that causes red blood cells to be misshapen like a sickle. Normal red blood cells are round and carry oxygen smoothly through blood vessels. In sickle cell disease, the abnormal cells block blood flow and break apart easily, leading to problems like severe pain, liver and heart issues, and a shorter life span, typically in the mid-40s. Medications can help manage the disease, but a cure is possible only through a blood or marrow transplant, which has risks and often requires a sibling donor.

The RUBY Trial is sponsored by Editas Medicine.

END

ELSE PRESS RELEASES FROM THIS DATE:

Technique improves the reasoning capabilities of large language models

2024-06-14

CAMBRIDGE, MA - Large language models like those that power ChatGPT have shown impressive performance on tasks like drafting legal briefs, analyzing the sentiment of customer reviews, or translating documents into different languages. These machine-learning models typically use only natural language to process information and answer queries, which can make it difficult for them to perform tasks that require numerical or symbolic reasoning. For instance, a large language model might be able to memorize and recite a list of recent U.S. presidents and their birthdays, but that same model could fail if asked the question “Which U.S. presidents elected after 1950 ...

URI study examines challenges, barriers to care for individuals leaving residential substance use facilities

2024-06-14

Residential treatment is among the most effective tools for treating substance use disorder, with people in these settings showing improvement not only in their substance use but also in their mental health, social functioning and quality of life. However, when people leave residential substance use facilities, they face immense challenges as they attempt to reintegrate into their communities and return to their normal lives. As many as 40 to 70 percent of people who complete residential treatment return ...

Some CRISPR screens may be missing cancer drug targets

2024-06-14

CRISPR/Cas9 gene editing has made possible a multitude of biomedical experiments including studies that systematically turn off genes in cancer cells to look for ones that the cancer cells heavily depend on to survive and grow. These genes, or “cancer dependencies,” are often promising drug targets. But new research shows that many of these CRISPR screening experiments rely on components, called CRISPR/Cas9 guides, that do not perform equally well in cells from people of all ancestries, which can cause CRISPR screens to miss cancer dependencies. These CRISPR guides are short sequences of RNA that ...

$18.5 million U19 grant will study B and T memory cells in transplanted lungs, uteruses and kidneys

2024-06-14

BIRMINGHAM, Ala. – Memory immune cells reside in many tissues, poised to react to a second infection or continuing antigen. Yet little is known about these tissue-resident memory cells — how they get there, how they evolve and how they compete in tissues. A five-year, $18.5 million grant will allow University of Alabama at Birmingham researchers to investigate T and B tissue-resident memory cells, known as TRM and BRM cells, in three unique sites — transplanted lungs, transplanted kidneys and the transplanted ...

Improving soil health yields unexpected benefits for farmers

2024-06-14

In the U.S., as farmers wrestle with extreme heat and drought, heavy rainfall and flooding, and erosion—all factors of climate change which can take a toll on crops—there's been a lot of buzz over regenerative agriculture over the past few years, as big agriculture companies promise opportunities to make money from "carbon farming" while also improving soil health. Regenerative farming strives to improve soil health through various methods, including reduced or no tillage, keeping the soil covered year-round through ...

NYCST announces inaugural awards for space technology projects

2024-06-14

The New York Consortium for Space Technology (NYCST) is led by Cornell University, which is funded by the U.S. Department of Defense’s Office of Local Defense Community Cooperation through the Defense Manufacturing Community Support Program. Ithaca, NY— June 14, 2024 — The New York Consortium for Space Technology Innovation and Development (NYCST) today announced more than $300 thousand has been allocated to support 6 projects through the inaugural round of the consortium’s funding program. The projects were selected during NYCST’s inaugural ...

St. Jude scientists solve decades long mystery of NLRC5 sensor function in cell death

2024-06-14

(MEMPHIS, Tenn. – June 14, 2024) The innate immune system is responsible for protecting the human body from threats that could cause disease or infection. The system relies on innate immune sensors to detect and transmit signals about these threats. One of the key innate immune strategies to respond to threats is through cell death. New research from St. Jude Children’s Research Hospital discovered that NLRC5 plays a previously unknown role as an innate immune sensor, triggering cell death. The findings, published in Cell, show how NLRC5 drives PANoptosis, a prominent type of inflammatory cell death. This understanding has implications for the development of therapeutics ...

Gonadal function in male mice disrupted by prenatal risk factors

2024-06-14

Researchers have consistently shown that prenatal exposure to Di (2-ethyhexyl) phthalate harms the reproductive system in male mice and causes fertility defects. In a new study, scientists from the University of Illinois Urbana-Champaign have shown that the combination of DEHP and a high-fat diet in pregnant mice can cause more damage to pups than each factor alone. Male reproductive disorders are a growing issue due to the global decrease in sperm count and quality. Concerningly, chemicals like DEHP, which can be found in food storage containers, pharmaceuticals, and building materials, have been ...

Endangered sea cucumbers for sale in NYC food markets

2024-06-14

ITHACA, N.Y. - After surveying food market retailers in three New York City Chinatown districts, Cornell University researchers have found genetic evidence that some endangered species of sea cucumbers – considered a pricey but nutritious dried delicacy – are being sold to consumers. The researchers collected 103 samples of dried sea cucumbers from retail food shops. By using mitochondrial DNA testing, they successfully identified 74 examples of sea cucumbers. Eight were classified as brown sea cucumbers– which are threatened and found on the International Union for the Conservation of Nature (IUCN) Red List due to overharvesting. “We ...

Infectious H5N1 influenza virus in raw milk rapidly declines with heat treatment

2024-06-14

WHAT: The amount of infectious H5N1 influenza viruses in raw milk rapidly declined with heat treatment in laboratory research conducted by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. However, small, detectable amounts of infectious virus remained in raw milk samples with high virus levels when treated at 72 degrees Celsius (161.6 degrees Fahrenheit) for 15 seconds—one of the standard pasteurization methods used by the dairy industry. The authors of the study stress, ...

Scientists uncover the first clear evidence of air sacs in the fossilized bones of alvarezsaurian dinosaurs: the "hollow bones" which help modern day birds to fly

Alcohol makes male flies sexy

TB patients globally often incur "catastrophic costs" of up to $11,329 USD, despite many countries offering free treatment, with predominant drivers of cost being hospitalization and loss of income

Novel gene-editing therapy continues to show positive results in sickle cell patients

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: